ESR2 and cancer: Previous studies demonstrated that overexpression of ERβ or activation with ligands results in a decrease in proliferation and induction of apoptosis of cancer cells, and that depending on the cell type, activation of ERβ can promote either G2 or G1 arrest 14, 41.